Advanced bladder cancer: The need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) world Journal Article


Authors: Roth, B. J.; Bajorin, D. F.
Article Title: Advanced bladder cancer: The need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) world
Keywords: clinical trial; cisplatin; doxorubicin; fluorouracil; advanced cancer; cancer combination chemotherapy; dose response; antineoplastic agents; alpha interferon; gemcitabine; paclitaxel; methotrexate; neoplasm staging; carboplatin; metastasis; liver toxicity; nephrotoxicity; phase 2 clinical trial; antimetabolites, antineoplastic; blood toxicity; mucosa inflammation; nausea; vomiting; antineoplastic combined chemotherapy protocols; granulocyte macrophage colony stimulating factor; calcitriol; pyrimidines; ifosfamide; vinblastine; docetaxel; fever; rash; drug mechanism; mitoxantrone; urinary diversion; epirubicin; phase 3 clinical trial; bladder neoplasms; phase 1 clinical trial; drug half life; bladder carcinoma; deoxycytidine; granulocyte colony stimulating factor; hearing loss; intravenous drug administration; hypocalcemia; oral drug administration; intramuscular drug administration; gallium; trimetrexate; pirarubicin; piritrexim; anthraquinone; optic nerve disease; gallium nitrate; human; priority journal; article
Journal Title: Journal of Urology
Volume: 153
Issue: 3 Suppl.
ISSN: 0022-5347
Publisher: Elsevier Science, Inc.  
Date Published: 1995-03-01
Start Page: 894
End Page: 900
Language: English
DOI: 10.1016/s0022-5347(01)67598-0
PUBMED: 7853569
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 28 August 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dean Bajorin
    657 Bajorin